2018 IPCC Attendee List

Size: px
Start display at page:

Download "2018 IPCC Attendee List"

Transcription

1 2018 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2018 Title Head of Intellectual Property Vice President IP Asst. Program Officer Health Supervisor Public Health Asst. Health Youth Coordinator IP European Patent Senior Co-chair of the Intellectual Property Group Job Title IP European Patent General Manager Consultant, IP Strategy & Policy Patent Director Company Name Abel & Imray Akebia Therapeutics, Inc Alkermes, Inc. Alnylam Pharmaceuticals, Inc. Asabe Shehu Yar'adua Foundation Asabe Shehu Yar'adua Foundation Asabe Shehu Yar'adua Foundation Asabe Shehu Yar'Adua Foundation Biogen Bird & Bird Carpmaels & Ransford Carpmaels & Ransford Carpmaels & Ransford Choate, Hall & Stewart Choate, Hall & Stewart Choate, Hall & Stewart Company Name Cooley Dannemann Siemsen Dechert Dennemeyer & s DGIP El-Hamiz Sarl Eli Lilly and Company Emory University European Patent Office 1

2 Equity Vice President, Intellectual Property Head of IP Senior Director IP and Chief Patent Director, Legal Affairs - Head of IP Chief IP, Patent Founding Forresters Genentech, A Member of the Roche Group GreenLight Biosciences ImmunoGen, Inc. Intercept Pharmaceuticals, Inc Ironwood Pharmaceuticals, Inc. J A Kemp Jones Day Kilburn & Strode Lathrop Gage McAndrews, Held & Malloy McNeill Baur PLLC McNeill Baur PLLC 2

3 Director, Intellectual Property General, IP General, IP General, IP General, IP IP Senior IP VP Chief Intellectual Property Principal, Head of Biologic Patents US Chief Intellectual Property Senior Vice President, Chief Intellectual Property Vice President-IP Legal Assistant Proffecer, Patent Agent Vice President, Chief IP Patent Executive Director Director-Intellectual Property Director Deputy General & Vice President and Director, Intellectual Property Policy Director, Event Operations Coordinator, Education Manager, Sales and Sponsorship Miragen Therapeutics, Inc. Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Monsanto Company Morrison & Foerster, Morrison & Foerster, Novo Nordisk Novo Nordisk Regeneron Pharmaceuticals, Inc. Sanofi Sarepta Therapeutics, Inc. Sliet University Smart & Biggar/Fetherstonhaugh Vertex Pharmaceuticals Incorporated Wallinger Ricker Schlotter Tostmann Parker Institute For Cancer Immunotherapy Texas Tech Office of Research Commercialization University of Iowa Research Foundation 3

4 Executive Vice President & General Cousnel Senior Vice President & General Divisional Director, IP Senior Corporate IP, Legal Patent Senior Vice President - Litigation Senior Director IP and Chief Patent Vice President Patent Law/Assistant Patent Senior Director, Patents Assistant Chief IP Vice President, General Senior Vice President, Chief Intellectual Property Senior Patent Vice President, IP, Endocrinology & R&D Peptides Chief IP Officer Vice President, Intellectual Property Board Senior Director, IP Senior Director IP Roche Molecular Systems, Inc. Senior Patent Patent Engineer Patent / Shareholder Epizyme, Inc. GlaxoSmithKline AbbVie Inc. Alkermes, Inc. Alnylam Pharmaceuticals, Inc Astellas US LLC Bayer CropScience, Inc. Horizon Pharma, plc ImmunoGen, Inc Johnson and Johnson Juno Therapeutics, Inc. Novo Nordisk Roche Molecular Systems, Inc. Tesaro, Inc. Ipsen Bioscience Kiniksa Pharmaceuticals Neurocrine Biosciences, Inc Teles Patent Right International Gmbh Zymeworks Inc Alkermes, Inc. Alnylam Pharmaceuticals, Inc Roche Molecular Teles Patent Right International Gmbh Brinks Gilson & Lione 4

5 Lawyer President Equity Principal Consultant VP, IP and Licensing Assistant General Senior Patent Director, Patent A/S Senior Technology and Litigation Senior Director, Legal Affairs U.S. Chief Patent df-mp Dunner, LL Morrison & Foerster Rothwell Figg WilmerHale WilmerHale Carpmaels & Ransford Dannemann Siemsen Elmore Patent Law Group, PC Forresters Lee & Ko Shelston Ip Sunstein Kann Murphy & Timbers Life Sciences Innovation LLC Nelson Mullins Riley & Scarborough Exelixis, Inc Genentech, Inc. GlaxoSmithKline Regeneron Pharmaceuticals, Inc Bavarian Nordic, Inc Coherus Biosciences Genentech, Inc. McCarter & English, Myriad Genetics, Inc Novozymes 5

6 Shareholder, Chair Intellectual Property Law Department Equity Founding Member U.S. Patent & Trademark Office BakerHostetler Brinks Gilson & Lione Brinks Gilson & Lione Fenwick & West Fenwick & West Fenwick & West Foley Hoag Foley Hoag Foley Hoag Forresters McDermott, Will & Emery McNeill Baur PLLC Morrison & Foerster Nutter Rothwell Figg Rothwell Figg Seed Intellectual Property Law Group WilmeHale WilmerHale 6

2017 IPCC Attendee List

2017 IPCC Attendee List 2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.

More information

IP Counsels FALL CONFERENCE PROGRAM GUIDE. Committee Conference ANNAPOLIS, MD NOVEMBER 13 15, Program Guide sponsored by

IP Counsels FALL CONFERENCE PROGRAM GUIDE. Committee Conference ANNAPOLIS, MD NOVEMBER 13 15, Program Guide sponsored by IP Counsels Committee Conference 2017 FALL CONFERENCE ANNAPOLIS, MD NOVEMBER 13 15, 2017 PROGRAM GUIDE Program Guide sponsored by Program Agenda PROGRAM AGENDA ANNAPOLIS, MD NOVEMBER 13 15, 2017 All Sessions

More information

European Patent Reform Forum USA December , New York

European Patent Reform Forum USA December , New York European Patent Reform Forum USA December 8 2015, New York Delegate List Job Title Organisation SVP/ Senior IP Law ACell ADP Law Vice President Director Senior Manager, Licensing, IP Law Global, Diabetes

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable

More information

PROGRAM AGENDA FOUR SEASONS HOTEL ST. LOUIS ST. LOUIS, MO APRIL 15-17, 2015

PROGRAM AGENDA FOUR SEASONS HOTEL ST. LOUIS ST. LOUIS, MO APRIL 15-17, 2015 PROGRAM AGENDA FOUR SEASONS HOTEL ST. LOUIS ST. LOUIS, MO APRIL 15-17, 2015 Wednesday, April 15, 2015 Registration 11:30 am 3:30 pm Four Seasons Hotel St. Louis Ballroom Lobby, 6 th Floor Please pick up

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar

More information

PROGRAM AGENDA ST. REGIS HOTEL WASHINGTON, D.C. OCTOBER 26-28, 2009

PROGRAM AGENDA ST. REGIS HOTEL WASHINGTON, D.C. OCTOBER 26-28, 2009 PROGRAM AGENDA ST. REGIS HOTEL WASHINGTON, D.C. OCTOBER 26-28, 2009 MONDAY, OCTOBER 26, 2009 IP Counsels Committee Retreat & 12:00 pm 3:30 pm Working Luncheon BIO Office Jefferson Conference Rooms 1201

More information

Contents. Introduction & Methodology. Credits & Contact. Introduction & Methodology 3. PE Firms Q&A: Donnelley Financial Solutions 12-14

Contents. Introduction & Methodology. Credits & Contact. Introduction & Methodology 3. PE Firms Q&A: Donnelley Financial Solutions 12-14 Contents Introduction & Methodology 3 PE Firms 4-11 Q&A: Donnelley Financial Solutions 12-14 VC Firms 16-21 Advisors/Accountants & Investment Banks 22-27 Law Firms 28-36 Acquirers 37-39 Credits & Contact

More information

Corporate Compliance & Transparency

Corporate Compliance & Transparency 4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating

More information

Copies of the Agenda for all Committee meetings to be provided onsite.

Copies of the Agenda for all Committee meetings to be provided onsite. BIO S INTELLECTUAL PROPERTY COUNSELS COMMITTEE FALL CONFERENCE & COMMITTEE MEETING PROGRAM HARD ROCK HOTEL AT UNIVERSAL ORLANDO ORLANDO, FLORIDA OCTOBER 20 22, 2008 MONDAY, OCTOBER 20, 2008 Welcome, Conference

More information

PROGRAM GUIDE IP Counsels. Committee Conference. Program Guide sponsored by SPRING CONFERENCE

PROGRAM GUIDE IP Counsels. Committee Conference. Program Guide sponsored by SPRING CONFERENCE PROGRAM GUIDE IP Counsels Committee Conference 2017 SPRING CONFERENCE NEWPORT BEACH, CA MARCH 27 29, 2017 Program Guide sponsored by FALL 2017 BIO INTELLECTUAL PROPERTY CONFERENCE COUNSELS COMMITTEE IP

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

SPRING CONFERENCE. IP Counsels PROGRAM GUIDE. APRIL 11 13, 2018 New Orleans, LA. Committee Conference

SPRING CONFERENCE. IP Counsels PROGRAM GUIDE. APRIL 11 13, 2018 New Orleans, LA. Committee Conference Committee Conference 2018 BIO INTELLECTUAL PROPERTY COUNSELS COMMITTEE 2018 SPRING APRIL 11 13, 2018 New Orleans, LA CONFERENCE PROGRAM GUIDE Program Guide sponsored by Committee Conference TABLE OF CONTENTS

More information

Program as of November 1, 2016

Program as of November 1, 2016 Monday, November 14, 2016 Registration Open 11:30 am - 3:30 pm Program as of November 1, 2016 IPCC Business Meeting & Working Luncheon 12:00 pm 3:15 pm *Open to IP Counsels Committee company members only

More information

PROGRAM AGENDA HOTEL 1000 SEATTLE, WASHINGTON APRIL 13-15, 2011

PROGRAM AGENDA HOTEL 1000 SEATTLE, WASHINGTON APRIL 13-15, 2011 PROGRAM AGENDA HOTEL 1000 SEATTLE, WASHINGTON APRIL 13-15, 2011 WEDNESDAY, APRIL 13, 2011 Registration Hotel 1000 Level 4 Foyer 1000 First Avenue Seattle, WA 98104 11:30 am 3:30 pm Please come to pick

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated

More information

Method of Declaration. Hospitality/Interest/Sponsorship

Method of Declaration. Hospitality/Interest/Sponsorship Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12

More information

Patent Masters Symposium A part of the IPWatchdog Institute

Patent Masters Symposium A part of the IPWatchdog Institute Patent Masters Symposium A part of the IPWatchdog Institute Program Agenda * Monday, March 25, 2019 8:30am to 9:00am Registration & Continental Breakfast 9:00am to 9:15am Gene Quinn: Welcome & Introductions

More information

PROGRAM SCHEDULE FACULTY BIOS... 33

PROGRAM SCHEDULE FACULTY BIOS... 33 Prepared for distribution at the PATENT LITIGATION 2015 Program October November 2015 CONTENTS: PROGRAM SCHEDULE... 11 FACULTY BIOS... 33 1. Recent Appellate Cases and Developments in Patent Law and Litigation

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID

More information

Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer

Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until

More information

TRENDS IN IP DISPUTES

TRENDS IN IP DISPUTES ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating

More information

Patent Masters Symposium A part of the IPWatchdog Institute

Patent Masters Symposium A part of the IPWatchdog Institute Patent Masters Symposium A part of the IPWatchdog Institute Program Agenda * Monday, March 25, 2019 8:30am to 9:00am Registration & Continental fast 9:00 to 9:15am Gene Quinn: Welcome & Introductions Session

More information

2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions

2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions 2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions FRIDAY, 4 MAY 8:30 AM 3 PM New York Genome Center 101 Avenue of the Americas New York, NY 10013 HBAnet.org Event

More information

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017 BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400

More information

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

Protection of Biological Materials in India Patent Truths and Untruths

Protection of Biological Materials in India Patent Truths and Untruths Patent Workshop Patentability of biological materials, isolated or derived from living organisms Monday, November 19th, 2018, Peacock Ballroom 1, Pullman Hotel 13:15-17:15 hours a. s i. Mr. Hari Subramaniam,

More information

Jay Ash Secretary of Housing & Economic Development, Commonwealth of Massachusetts

Jay Ash Secretary of Housing & Economic Development, Commonwealth of Massachusetts 8:00-9:00 am Breakfast and Registration Foyer 9:00-9:30 am Welcome Remarks, Overview of Meeting & MassBio Board Elections Robert K. Coughlin President & Chief Executive Officer, MassBio Glenn Batchelder

More information

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager

More information

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,

More information

IP Boutiques Tick Down As AIA Settles In

IP Boutiques Tick Down As AIA Settles In Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com IP Boutiques Tick Down As AIA Settles In

More information

IP for Development Indian Approach

IP for Development Indian Approach ARAB REPUBLIC OF EGYPT MINISTRY OF FOREIGN AFFAIRS ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY WORLD INTELLECTUAL PROPERTY ORGANISATION Second WIPO Inter-Regional Meeting on South-South Cooperation on

More information

FACILITIES OF THE FUTURE. Innovating the Future of Manufacturing FEBRUARY REGISTER NOW!

FACILITIES OF THE FUTURE. Innovating the Future of Manufacturing FEBRUARY REGISTER NOW! FACILITIES OF THE FUTURE C O N F E R E N C E Innovating the Future of Manufacturing 20 22 FEBRUARY 2018 Marriott Hotel & Conference Center Bethesda, MD Register by 11 January and Receive $200 OFF REGISTER

More information

Eric J. Marandett. Practice Group Leader PRACTICE FOCUS. T +1 (617)

Eric J. Marandett. Practice Group Leader PRACTICE FOCUS. T +1 (617) Eric J. Marandett Practice Group Leader T +1 (617) 248-5287 emarandett@choate.com very business-savvy and [clients ] first port of call for litigation Chambers USA Eric Marandett represents biotech, pharmaceutical

More information

Annual Benefit-Risk Workshop

Annual Benefit-Risk Workshop Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

Hot Topics In Intellectual Property Litigation

Hot Topics In Intellectual Property Litigation Hot Topics In Intellectual Property Litigation Second Annual Intellectual Property Litigation Regional CLE Workshop Friday, June 8, 2012 Hosted by Schiff Hardin LLP 233 S. Wacker Drive Chicago, Illinois

More information

Celebrating International Women's Day Friday, March 8, :30am-1:00pm

Celebrating International Women's Day Friday, March 8, :30am-1:00pm Co-Hosted by: Join us in Launching the 1st Annual Successful Women of San Diego Executive Leadership Panel Celebrating International Women's Day Friday, March 8, 2019 11:30am-1:00pm Sponsored by: Location:

More information

IP Forum For Pharmaceuticals, Biotechnology & Medical Devices

IP Forum For Pharmaceuticals, Biotechnology & Medical Devices IP Forum For Pharmaceuticals, Biotechnology & Medical Devices December 8-10, 2013 Fairmont Newport Beach Hotel Newport Beach, CA Fairmont Newport Beach Hotel 4500 MacArthur Blvd Newport Beach, CA 92660

More information

Workshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review?

Workshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review? Workshop on Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review? 6 7 December 2011 PROGRAMME Intercontinental Hotel, Kuala

More information

Founder Follies. Presentation for Harvard Business School. February 9, Jeffrey L. Quillen Alexander J. Aber

Founder Follies. Presentation for Harvard Business School. February 9, Jeffrey L. Quillen Alexander J. Aber Founder Follies Presentation for Harvard Business School February 9, 2012 Jeffrey L. Quillen Alexander J. Aber 2012 Foley Hoag LLP. All Rights Reserved. These materials have been prepared solely for educational

More information

Follow this and additional works at: Part of the Business Organizations Law Commons

Follow this and additional works at:   Part of the Business Organizations Law Commons University of Richmond UR Scholarship Repository Law Faculty Publications School of Law 2015 Business Structures David G. Epstein University of Richmond, depstein@richmond.edu Follow this and additional

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable

More information

POST EVENT REPORT IP Life Sciences Exchange 2015

POST EVENT REPORT IP Life Sciences Exchange 2015 POST EVENT REPORT IP Life Sciences Exchange 2015 A vivid cross-section of present IP challenges, interwoven with opportunities to discuss present needs with solution providers. Deputy Head of IP Egis Pharmaceuticals

More information

2017 Author Biographies

2017 Author Biographies 2017 Author Biographies Rouget F. (Ric) Henschel Chapter 1: The State of the Law of Claim Construction and Infringement Rouget F. (Ric) Henschel is a partner at Foley & Lardner LLP. He is a member of the

More information

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis

More information

W80947VT2RIB 94 Day RM

W80947VT2RIB 94 Day RM Genetic Family: W02STXRIB W04VT2RIB 4 Day RM Manage for top-end yield Wide area of adaptation Strong agronomic package 114 224 30000-3000 1-1 Pink - Tall Wensman and Design are registered trademarks of

More information

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data

More information

Industry Advisory Board Harper Cancer Research Institute

Industry Advisory Board Harper Cancer Research Institute Industry Advisory Board Harper Cancer Research Institute Gaylene Anderson, M.B.A. US Director Contracts and Alliance Management Boehringer Ingelheim Pharmaceuticals Gaylene is the US Director of Contracts

More information

Workshop. Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences

Workshop. Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences Workshop Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences WORKSHOP PROGRAMME 4-5 May 2009 OECD Headquarters 2, Rue Andre-Pascal, 75016 Paris For

More information

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision

More information

Overview + Sponsorship Opportunities. Advancing LGBT+ diversity in corporate governance

Overview + Sponsorship Opportunities. Advancing LGBT+ diversity in corporate governance Overview + Sponsorship Opportunities Advancing LGBT+ diversity in corporate governance Our Purpose: Ensuring LGBT+ diversity is central in conversations about board representation and policy. Quorum is

More information

We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations

We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have

More information

IIPTA. Role of Intellectual Property Rights in Biotechnology Industry. Launch a Career. Be Awesome

IIPTA. Role of Intellectual Property Rights in Biotechnology Industry.  Launch a Career. Be Awesome IIPTA Launch a Career. Be Awesome www.iipta.com Role of Intellectual Property Rights in Biotechnology Industry INTRODUCTION TO THE WORKSHOP Intellectual Property Rights is a tool to protect innovation

More information

FLYNN THIEL. Welcome. Attorneys specializing in intellectual property law since

FLYNN THIEL. Welcome. Attorneys specializing in intellectual property law since Welcome Our office is located in Kalamazoo, Michigan. We are a boutique law firm that provides a range of services relating to patents, trademarks, and all other intellectual property matters. Comprising

More information

HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging

HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of

More information

William E. Solander. Case Highlight

William E. Solander. Case Highlight ...an insightful patent litigator with sound judgment who is capable of achieving effective results when solving legal and business issues. (Best Lawyers 2014) Contact William E. Solander Partner wsolander@fchs.com

More information

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be

More information

Previous Attendees List:

Previous Attendees List: Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare

More information

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D. Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology

More information

VentureSource Europe -- 3Q 2014

VentureSource Europe -- 3Q 2014 Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a

More information

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT

More information

TODAY LETTER DATED

TODAY LETTER DATED TODAY LETTER DATED 05.07.2018 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD-380054 23483 CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE-

More information

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION utrf@tennessee.com TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION Hot Topics in Research, May 23, 2017 Richard Magid, PhD UTRF Vice President WHAT IS TECHNOLOGY TRANSFER?

More information

Law360 Names Practice Groups Of The Year

Law360 Names Practice Groups Of The Year Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Law360 Names Practice Groups Of The Year By Jake Simpson

More information

Aqua Pharmaceuticals, LLC

Aqua Pharmaceuticals, LLC Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing

More information

NOTICE OF ANNUAL GENERAL MEETING. Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on:

NOTICE OF ANNUAL GENERAL MEETING. Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on: TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on: Thursday, 21 March 2013 at 10:00 AM The Annual

More information

TWO GREAT REASONS FOR YOUR LAW FIRM TO JOIN IPO IN 2019 BUSINESS DEVELOPMENT AND NETWORKING ELEVATE YOUR PROFILE IN A CROWDED IP LEGAL MARKETPLACE

TWO GREAT REASONS FOR YOUR LAW FIRM TO JOIN IPO IN 2019 BUSINESS DEVELOPMENT AND NETWORKING ELEVATE YOUR PROFILE IN A CROWDED IP LEGAL MARKETPLACE SERVING THE INTELLECTUAL PROPERTY COMMUNITY WORLDWIDE TWO GREAT REASONS FOR YOUR LAW FIRM TO JOIN IPO IN 2019 BUSINESS DEVELOPMENT AND NETWORKING ELEVATE YOUR PROFILE IN A CROWDED IP LEGAL MARKETPLACE

More information

From the Bench to the Bar

From the Bench to the Bar From the Bench to the Bar (No, not that kind of bar) Patent Law Careers for Scientists Edward Ergenzinger, J.D., Ph.D. Director of Intellectual Property Duke Human Vaccine Institute July 27, 2010 Today

More information

The 11th Annual CIPA Congress

The 11th Annual CIPA Congress Updated Programme Getting it Right Best Practice in International IP The 11th Annual CIPA Congress Programme and Registration Radisson SAS Portman Hotel Portman Square London W1 2-3 November 2006 Programme

More information

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &

More information

Larry R. Laycock. Education. Practice Focus. Attorney at Law Shareholder

Larry R. Laycock. Education. Practice Focus. Attorney at Law Shareholder Larry R. Laycock Attorney at Law Shareholder Larry has extensive experience as lead trial counsel in complex and intellectual property litigation. His practice includes patent, trademark, trade secret,

More information

Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None

Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,

More information

Life Sciences Outlook. New York City 2016

Life Sciences Outlook. New York City 2016 Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and

More information

Jan Cobbenhagen. E: W:

Jan Cobbenhagen. E: W: Jan Cobbenhagen Jan Cobbenhagen (1963) is active in the business and academic communities. He holds both CEO and supervisory positions. His current responsibilities are: CEO of Maastricht University Holding

More information

Half-Day Seminar on. Life Sciences Patent Protection in US and India

Half-Day Seminar on. Life Sciences Patent Protection in US and India Half-Day Seminar on Life Sciences Patent Protection in US and India LEARN FOR WHOM Learn about the scope and strategies of patent protection in the US (world s largest market for biotech products) and

More information

Tom Kähler. Schedule 2. Candidates for the Board of Directors. Chairman Born 11 June 1943 Nationality: Danish

Tom Kähler. Schedule 2. Candidates for the Board of Directors. Chairman Born 11 June 1943 Nationality: Danish Schedule 2 Candidates for the Board of Directors Tom Kähler Chairman Born 11 June 1943 1971: Graduate Diploma in Business Administration (HD), Copenhagen Business School 1968: MSc (Engineering) (chemistry),

More information

5 th Annual Pharma IPR Conference 2016

5 th Annual Pharma IPR Conference 2016 5 th Annual Pharma IPR Conference 2016 9 11 March 2016, Mumbai DAY 1 : 9 th March 2016 Country: US 09:40 American Invents Act Updates on Americas Invents Act and current scenario of US Patent laws Implications

More information

MEET THE ENTREPRENEUR ANKER LUNDEMOSE

MEET THE ENTREPRENEUR ANKER LUNDEMOSE MEET THE ENTREPRENEUR ANKER LUNDEMOSE MTIC AARHUS 14 NOVEMBER 2011 EXPERIENCES OF AN ENTREPRENEUR Serial entrepreneur and founder of several biotech companies including Symphogen A/S, Santaris Pharma A/S,

More information

Transforming the right molecules into the best medicines TM

Transforming the right molecules into the best medicines TM August 2017 Transforming the right molecules into the best medicines TM We are passionate in our mission to improve the health of patients by providing novel strategic alternatives to companies wishing

More information

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT. Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,

More information

Author Biographies. Rouget F. (Ric) Henschel and Michael D. Kaminski Chapter 1: The State of the Law of Claim Construction and Infringement

Author Biographies. Rouget F. (Ric) Henschel and Michael D. Kaminski Chapter 1: The State of the Law of Claim Construction and Infringement Author Biographies Rouget F. (Ric) Henschel and Michael D. Kaminski Chapter 1: The State of the Law of Claim Construction and Infringement Rouget F. (Ric) Henschel is a partner at Foley & Lardner LLP.

More information

CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within

More information

Women leaders transforming the future through gender partnership

Women leaders transforming the future through gender partnership On behalf of the 3BC steering committee, HBA senior advisory board and board of directors, we wish to warmly invite you to: Building Better Business Connections (3BC) annual executive summit Women leaders

More information

Remaining Competitive

Remaining Competitive Remaining Competitive Silvia Coulter, Principal FICPI Canada, February 2016 2015 LawVision. All rights reserved. World-Wide Granted Patents Filings Since 2009 Leveled out significantly in the past 5 years

More information

Chief Trademark Counsel Teva Pharmaceuticals, Inc.

Chief Trademark Counsel Teva Pharmaceuticals, Inc. David S. Weinstock, Esq. Program Moderator David Weinstock has served as in-house and outside counsel advising prescription and OTC drug, biotech, medical device and cosmetic companies, including Boehringer

More information

Li-H Partner INDUSTRIES. by Chambers counsels clients. Rin-Laures is. Pharmaceutical. been featured. Practitioners" Patent Prosecution.

Li-H Partner INDUSTRIES. by Chambers counsels clients. Rin-Laures is. Pharmaceutical. been featured. Practitioners Patent Prosecution. Li-H Partner Hsien (Lily) Rin-Laures, M.D. Tel 312.474.6641 lrinlaures@marshallip.com Dr. Li-Hsien (Lily) Rin-Laures is a leading partner in "one of the best biotechnology practices in the country," as

More information

Pharma Patent Lifecycles

Pharma Patent Lifecycles 9th Annual International Maximising Pharma Patent Lifecycles Business Information In A Global Context The Latest Legal and Regulatory Developments and Successful Strategies for Lifecycle Extension 23 and

More information

Pergamon Corporation CONFRENCE

Pergamon Corporation CONFRENCE Pergamon Corporation CONFRENCE IP Stategy, Patent Portfolio Development and InnovationEarn CLE Dissecting the evolving spectrum of intellectual property rights, and licensing to foster innovation May 23-24,

More information

Case Law Seminar. epi - EPO roadshow for professional representatives. Programme. 29 October 2018 Paris, France

Case Law Seminar. epi - EPO roadshow for professional representatives. Programme. 29 October 2018 Paris, France Case Law Seminar epi - EPO roadshow for professional representatives Programme 29 October 2018 Paris, France Monday, 29 October 2018 8.30 9.00 Registration 9.00 10.45 Claims Disclaimers (G2/03, G2/10,

More information

Licensing League Tables 3Q14

Licensing League Tables 3Q14 BioPharm Insight Licensing League Tables Table of Contents League Tables Global League Tables of Legal Advisors for...2 Global League Tables of Legal Advisors for...3 North American League Tables of Legal

More information

United States. United Kingdom: Barristers. Best of the best. Rankings editorial

United States. United Kingdom: Barristers. Best of the best. Rankings editorial United Kingdom: Barristers Juniors Joe Delaney Three New Square Chambers Thomas Hinchliffe Three New Square Chambers Andrew Lykiardopoulos 8 New Square Chambers of Mark Platts-Mills QC Thomas Mitcheson

More information

Intellectual Property Policy. DNDi POLICIES

Intellectual Property Policy. DNDi POLICIES Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments

More information

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations February 11-12, 2019 New York Marriott Marquis Now in its 21 st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and

More information

Cross-Border R&D in China Understanding the Regulatory Challenges

Cross-Border R&D in China Understanding the Regulatory Challenges 1 2 Cross-Border R&D in China Understanding the Regulatory Challenges 1 Panelists Moderator: Paul A. Stewart, Silicon Valley Office Managing Partner, Foley & Lardner LLP Speakers: David Rosen, Partner,

More information